0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Analysis and Commentary Guest User 9/20/19 Analysis and Commentary Guest User 9/20/19

More Questions and More Answers ... Once Again

Read More
Analysis and Commentary Guest User 9/13/19 Analysis and Commentary Guest User 9/13/19

CR-Level Funding at Start of FY 20 Approaches Certainty

Read More
Analysis and Commentary Guest User 9/6/19 Analysis and Commentary Guest User 9/6/19

Much to Gain from a Smooth Appropriations Process

Read More
Analysis and Commentary Guest User 8/23/19 Analysis and Commentary Guest User 8/23/19

Sometimes Things Just Don't Go as Planned (or Hoped)

Read More
Analysis and Commentary Guest User 8/11/19 Analysis and Commentary Guest User 8/11/19

Angling for Optimism

Read More
Analysis and Commentary Guest User 8/2/19 Analysis and Commentary Guest User 8/2/19

From Budget Deal to FY 20 Appropriations: Reasons for Optimism?

Read More
Analysis and Commentary Guest User 7/26/19 Analysis and Commentary Guest User 7/26/19

A Budget Deal Seems to Be in Place ... But There Are More Questions

Read More
Analysis and Commentary Guest User 7/19/19 Analysis and Commentary Guest User 7/19/19

No Guarantees for a Bright Future

Read More
Analysis and Commentary Guest User 7/12/19 Analysis and Commentary Guest User 7/12/19

Education and Advocacy for FDA Is a Year-Round Priority

Read More
Analysis and Commentary Guest User 6/29/19 Analysis and Commentary Guest User 6/29/19

What CBO Had to Say about Our Long-term Fiscal Health

Read More
Analysis and Commentary Guest User 6/24/19 Analysis and Commentary Guest User 6/24/19

Theory and Practice: How Appropriations Will Actually Work for FY 20

Read More
Analysis and Commentary Guest User 5/31/19 Analysis and Commentary Guest User 5/31/19

The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy

Read More
Analysis and Commentary Guest User 5/23/19 Analysis and Commentary Guest User 5/23/19

House Mark-up for FY 20 Very Pleasing

Read More
Analysis and Commentary Guest User 5/17/19 Analysis and Commentary Guest User 5/17/19

Regular Order Appropriations: Enshrined in Law, but Not in Practice

Read More
Analysis and Commentary Guest User 5/10/19 Analysis and Commentary Guest User 5/10/19

Potential Promise ... But Storm Clouds on Horizon

Read More
Analysis and Commentary Guest User 5/3/19 Analysis and Commentary Guest User 5/3/19

Federal Budgeting: A Brief Refresher Course

Read More
Analysis and Commentary Guest User 4/19/19 Analysis and Commentary Guest User 4/19/19

Gains and Gaps in Knowledge about Shutdown Processes

Read More
Analysis and Commentary Guest User 4/12/19 Analysis and Commentary Guest User 4/12/19

FY 20: The "Ask"; the Possible; and the Realities

Read More
Analysis and Commentary Guest User 3/29/19 Analysis and Commentary Guest User 3/29/19

What Chairman Hoeven Said, and Why

Read More
Analysis and Commentary Guest User 3/22/19 Analysis and Commentary Guest User 3/22/19

Sorting Out the Details of the President's FY 20 Request

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.